Effect of Teneligliptin versus Sulfonylurea on Major Adverse Cardiovascular Outcomes in People with Type 2 Diabetes Mellitus: A Real-World Study in Korea-Reference-Cited by-同舟云学术

Effect of Teneligliptin versus Sulfonylurea on Major Adverse Cardiovascular Outcomes in People with Type 2 Diabetes Mellitus: A Real-World Study in Korea

Published:2021-02-28 Issue:1 Volume:36 Page:70-80
ISSN:2093-596X
Container-title:Endocrinology and Metabolism
language:en
Short-container-title:Endocrinol Metab

Author:

Seo Da Hea^ORCID,Ha Kyoung Hwa^ORCID,Kim So Hun^ORCID,Kim Dae Jung^ORCID

Funder

Inha University

National Health Insurance Service

Publisher

Korean Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://e-enm.org/upload/pdf/enm-2020-777.pdf

Reference43 articles.

1. Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism

2. Update on Cardiovascular Safety of Incretin-Based Therapy in Adults With Type 2 Diabetes Mellitus: A Meta-Analysis of Cardiovascular Outcome Trials

3. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

4. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

5. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between Age at Diagnosis of Type 2 Diabetes and Subsequent Risk of Dementia and Its Major Subtypes;Journal of Clinical Medicine;2024-07-26

2. Association between age at diagnosis of type 2 diabetes and cardiovascular morbidity and mortality risks: A nationwide population-based study;Diabetes Research and Clinical Practice;2024-02

3. Finding the most cost-effective option from commonly used Dipeptidyl peptidase-4 inhibitors in India: a systematic study;Expert Review of Endocrinology & Metabolism;2023-05-26

4. Systematic review and meta-analysis of teneligliptin for treatment of type 2 diabetes;Journal of Endocrinological Investigation;2023-01-09

5. Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes;The Journal of Clinical Endocrinology & Metabolism;2022-09-15